These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 609725

  • 21. [Conception and systematics of clinical follow-up therapy of mammary carcinoma (author's transl)].
    Leonhardt A.
    MMW Munch Med Wochenschr; 1974 Jun 07; 116(23):1153-8. PubMed ID: 4369517
    [No Abstract] [Full Text] [Related]

  • 22. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
    Mannes P, Derriks R.
    Acta Tuberc Pneumol Belg; 1968 Jun 07; 59(2):445-54. PubMed ID: 5720490
    [No Abstract] [Full Text] [Related]

  • 23. Agents affecting osteolysis in patients with breast cancer.
    Coombes RC, Neville AM, Gazet JC, Ford HT, Nash AG, Baker JW, Powles JT.
    Cancer Chemother Pharmacol; 1979 Jun 07; 3(1):41-4. PubMed ID: 161206
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD, Charhon SA, Chapuy MC, Meunier PJ.
    Rev Rhum Mal Osteoartic; 1984 Dec 15; 51(11):663-6. PubMed ID: 6523018
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Metastatic carcinoma of the breast and hyperparathyroidism (author's transl)].
    Monsaingeon A, Ridoux G, Thomas J, Hamelin L.
    Chirurgie; 1978 Dec 15; 104(8):804-11. PubMed ID: 747975
    [No Abstract] [Full Text] [Related]

  • 33. [Hypophysectomy with ultrasonics in osseous metastases of breast carcinoma].
    Ricci V.
    Clin Ortop; 1971 Dec 15; 23(3):147-53. PubMed ID: 5161383
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Dissemination of secondaries of carcinoma into the bones (author's transl)].
    Moser H.
    Med Klin; 1974 Apr 26; 69(17):745-9. PubMed ID: 4837492
    [No Abstract] [Full Text] [Related]

  • 36. Clodronate for osteolytic metastases due to breast cancer.
    Elomaa I, Blomqvist C, Porkka L, Holmström T, Taube T, Lamberg-Allardt C, Borgström GH.
    Biomed Pharmacother; 1988 Apr 26; 42(2):111-6. PubMed ID: 2971403
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [A controlled clinical trial on adjuvant therapy by preoperative irradiation or postoperative cyclophosphamide in breast cancer (author's transl)].
    Berndt H, Eichhorn JH, Widow W.
    Arch Geschwulstforsch; 1980 Apr 26; 50(5):468-79. PubMed ID: 7006561
    [Abstract] [Full Text] [Related]

  • 39. Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis.
    Morony S, Capparelli C, Sarosi I, Lacey DL, Dunstan CR, Kostenuik PJ.
    Cancer Res; 2001 Jun 01; 61(11):4432-6. PubMed ID: 11389072
    [Abstract] [Full Text] [Related]

  • 40. A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden.
    Le Gall C, Bellahcène A, Bonnelye E, Gasser JA, Castronovo V, Green J, Zimmermann J, Clézardin P.
    Cancer Res; 2007 Oct 15; 67(20):9894-902. PubMed ID: 17942921
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.